Article ID Journal Published Year Pages File Type
8790373 Urologic Oncology: Seminars and Original Investigations 2017 9 Pages PDF
Abstract
Patients who achieve a long-term response after first-line TKI therapy could have a favorable prognosis with second-line mTT.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
Time to progression after first-line tyrosine kinase inhibitor predicts survival in patients with metastatic renal cell carcinoma receiving second-line molecular-targeted therapy
Authors
, , , , , , , , , , , , ,